Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 426

1.

Markers of microbial exposure lower the incidence of atopic dermatitis.

Chatenoud L, Bertuccio P, Turati F, Galeone C, Naldi L, Chatenoud L, La Vecchia C, Bach JF; HYGIENE Study Group.

Allergy. 2019 Jul 18. doi: 10.1111/all.13990. [Epub ahead of print]

PMID:
31321780
2.

Remission of chronic acne fulminans and severe hidradenitis suppurativa with targeted antibiotherapy.

Duchatelet S, Join-Lambert O, Delage M, Miskinyte S, Guet-Revillet H, Lam T, Coignard-Biehler H, Ungeheuer MN, Chatenoud L, Lortholary O, Nassif X, Hovnanian A, Nassif AS.

JAAD Case Rep. 2019 Jun 8;5(6):525-528. doi: 10.1016/j.jdcr.2019.04.001. eCollection 2019 Jun. No abstract available.

3.

Human peripheral blood DNAM-1neg NK cells are a terminally differentiated subset with limited effector functions.

Stannard KA, Lemoine S, Waterhouse NJ, Vari F, Chatenoud L, Gandhi MK, Martinet L, Smyth MJ, Guillerey C.

Blood Adv. 2019 Jun 11;3(11):1681-1694. doi: 10.1182/bloodadvances.2018030676.

4.

Infliximab Paradoxical Psoriasis in a Cohort of Children With Inflammatory Bowel Disease.

Courbette O, Aupiais C, Viala J, Hugot JP, Louveau B, Chatenoud L, Bourrat E, Martinez-Vinson C.

J Pediatr Gastroenterol Nutr. 2019 Aug;69(2):189-193. doi: 10.1097/MPG.0000000000002349.

PMID:
30921262
5.

Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immunodeficiencies and Inherited Disorders in Children.

Neven B, Diana JS, Castelle M, Magnani A, Rosain J, Touzot F, Moreira B, Fremond ML, Briand C, Bendavid M, Levy R, Morelle G, Vincent M, Magrin E, Bourget P, Chatenoud L, Picard C, Fischer A, Moshous D, Blanche S.

Biol Blood Marrow Transplant. 2019 Jul;25(7):1363-1373. doi: 10.1016/j.bbmt.2019.03.009. Epub 2019 Mar 12.

PMID:
30876929
6.

Psoriasis Incidence and Lifetime Prevalence: Suggestion for a Higher Mortality Rate in Older Age-classes among Psoriatic Patients Compared to the General Population in Italy.

Pezzolo E, Cazzaniga S, Colombo P, Chatenoud L, Naldi L.

Acta Derm Venereol. 2019 Apr 1;99(4):400-403. doi: 10.2340/00015555-3130.

7.

A future for CD3 antibodies in immunotherapy of type 1 diabetes.

Chatenoud L.

Diabetologia. 2019 Apr;62(4):578-581. doi: 10.1007/s00125-018-4808-7. Epub 2019 Jan 5. No abstract available.

PMID:
30612137
8.

Understanding Pathogenesis and Care Challenges of Immune Reconstitution Inflammatory Syndrome in Fungal Infections.

Dellière S, Guery R, Candon S, Rammaert B, Aguilar C, Lanternier F, Chatenoud L, Lortholary O.

J Fungi (Basel). 2018 Dec 17;4(4). pii: E139. doi: 10.3390/jof4040139. Review.

9.

Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency.

Briand C, Frémond ML, Bessis D, Carbasse A, Rice GI, Bondet V, Duffy D, Chatenoud L, Blanche S, Crow YJ, Neven B.

Ann Rheum Dis. 2019 Mar;78(3):431-433. doi: 10.1136/annrheumdis-2018-214037. Epub 2018 Oct 3. No abstract available.

PMID:
30282666
10.

Regulation of the β-cell inflammasome and contribution to stress-induced cellular dysfunction and apoptosis.

Ghiasi SM, Dahllöf MS, Osmai Y, Osmai M, Jakobsen KK, Aivazidis A, Tyrberg B, Perruzza L, Prause MCB, Christensen DP, Fog-Tonnesen M, Lundh M, Grassi F, Chatenoud L, Mandrup-Poulsen T.

Mol Cell Endocrinol. 2018 Dec 15;478:106-114. doi: 10.1016/j.mce.2018.08.001. Epub 2018 Aug 16.

PMID:
30121202
11.

Intensive care support and clinical outcomes of patients with Ebola virus disease (EVD) in West Africa.

Langer M, Portella G, Finazzi S, Chatenoud L, Lanini S, Vairo F, Fowler R, Miccio R, Ippolito G, Bertolini G, Strada G.

Intensive Care Med. 2018 Aug;44(8):1266-1275. doi: 10.1007/s00134-018-5308-4. Epub 2018 Jul 30.

12.

Efficacy of Rituximab in Refractory Generalized anti-AChR Myasthenia Gravis.

Landon-Cardinal O, Friedman D, Guiguet M, Laforêt P, Heming N, Salort-Campana E, Jouen F, Allenbach Y, Boyer O, Chatenoud L, Eymard B, Sharshar T, Benveniste O.

J Neuromuscul Dis. 2018;5(2):241-249. doi: 10.3233/JND-180300.

PMID:
29865089
13.

A selective CD28 antagonist and rapamycin synergise to protect against spontaneous autoimmune diabetes in NOD mice.

Besançon A, Goncalves T, Valette F, Mary C, Vanhove B, Chatenoud L, You S.

Diabetologia. 2018 Aug;61(8):1811-1816. doi: 10.1007/s00125-018-4638-7. Epub 2018 May 29.

PMID:
29845333
14.

Differential Impact of T-bet and IFNγ on Pancreatic Islet Allograft Rejection.

Besançon A, Demir Z, Goncalves T, Valette F, Panafieu E, Chatenoud L, You S.

Transplantation. 2018 Sep;102(9):1496-1504. doi: 10.1097/TP.0000000000002261.

PMID:
29757902
15.

Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes.

Orabona C, Mondanelli G, Pallotta MT, Carvalho A, Albini E, Fallarino F, Vacca C, Volpi C, Belladonna ML, Berioli MG, Ceccarini G, Esposito SM, Scattoni R, Verrotti A, Ferretti A, De Giorgi G, Toni S, Cappa M, Matteoli MC, Bianchi R, Matino D, Iacono A, Puccetti M, Cunha C, Bicciato S, Antognelli C, Talesa VN, Chatenoud L, Fuchs D, Pilotte L, Van den Eynde B, Lemos MC, Romani L, Puccetti P, Grohmann U.

JCI Insight. 2018 Mar 22;3(6). pii: 96244. doi: 10.1172/jci.insight.96244.

16.

Circulating IL-17-producing mucosal-associated invariant T cells (MAIT) are associated with symptoms in children with asthma.

Lezmi G, Abou Taam R, Dietrich C, Chatenoud L, de Blic J, Leite-de-Moraes M.

Clin Immunol. 2018 Mar;188:7-11. doi: 10.1016/j.clim.2017.11.009. Epub 2017 Nov 28.

PMID:
29196148
17.

Revisiting the phenotypic and genetic profiling of anergic T cells mediating long-term transplant tolerance.

You S, Chatenoud L.

Curr Opin Organ Transplant. 2018 Feb;23(1):83-89. doi: 10.1097/MOT.0000000000000494. Review.

PMID:
29194071
18.

Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice.

Besançon A, Goncalves T, Valette F, Dahllöf MS, Mandrup-Poulsen T, Chatenoud L, You S.

Diabetologia. 2018 Feb;61(2):389-398. doi: 10.1007/s00125-017-4459-0. Epub 2017 Oct 13.

PMID:
29030662
19.

The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes.

Mondanelli G, Albini E, Pallotta MT, Volpi C, Chatenoud L, Kuhn C, Fallarino F, Matino D, Belladonna ML, Bianchi R, Vacca C, Bicciato S, Boon L, Ricci G, Grohmann U, Puccetti P, Orabona C.

Front Immunol. 2017 Apr 13;8:428. doi: 10.3389/fimmu.2017.00428. eCollection 2017.

20.

The Induction and Maintenance of Transplant Tolerance Engages Both Regulatory and Anergic CD4+ T cells.

Besançon A, Baas M, Goncalves T, Valette F, Waldmann H, Chatenoud L, You S.

Front Immunol. 2017 Mar 6;8:218. doi: 10.3389/fimmu.2017.00218. eCollection 2017.

21.

Comparison of Trends in Mortality from Coronary Heart and Cerebrovascular Diseases in North and South America: 1980 to 2013.

Pagan E, Chatenoud L, Rodriguez T, Bosetti C, Levi F, Malvezzi M, La Vecchia C, Negri E, Bertuccio P.

Am J Cardiol. 2017 Mar 15;119(6):862-871. doi: 10.1016/j.amjcard.2016.11.040. Epub 2016 Dec 18.

PMID:
28139222
22.

Clinical Usefulness of Klebsiella Pneumoniae Carbapenemase-Producing K. Pneumoniae Genotyping: The Experience of a Single-Center Epidemic.

Rossi M, Chatenoud L, Viganò EF, Peri AM, Alagna L, Bramati S, Manenti M, Raggi M, Cavallero A, Bisi L, Leone S, Migliorino GM, Bandera A, Gori A.

Pathog Immun. 2017 Jan 9;1(2):352-370. doi: 10.20411/pai.v1i2.109. eCollection 2016.

23.

Revisiting autoimmune gastritis in children and adolescents with type 1 diabetes.

Besançon A, Michaud B, Beltrand J, Goncalves T, Jais JP, Polak M, Chatenoud L, Robert JJ.

Pediatr Diabetes. 2017 Dec;18(8):772-776. doi: 10.1111/pedi.12482. Epub 2016 Dec 22.

PMID:
28004477
24.

Control of asthma by omalizumab: the role of CD4+ Foxp3+ regulatory T cells.

Amat F, Tallon P, Foray AP, Michaud B, Lambert N, Saint-Pierre P, Chatenoud L, Just J.

Clin Exp Allergy. 2016 Dec;46(12):1614-1616. doi: 10.1111/cea.12839. No abstract available.

PMID:
27770456
25.

Mucosal administration of CD3-specific monoclonal antibody inhibits diabetes in NOD mice and in a preclinical mouse model transgenic for the CD3 epsilon chain.

Kuhn C, Rezende RM, da Cunha AP, Valette F, Quintana FJ, Chatenoud L, Weiner HL.

J Autoimmun. 2017 Jan;76:115-122. doi: 10.1016/j.jaut.2016.10.001. Epub 2016 Oct 10.

PMID:
27745778
26.

Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial.

Gottenberg JE, Brocq O, Perdriger A, Lassoued S, Berthelot JM, Wendling D, Euller-Ziegler L, Soubrier M, Richez C, Fautrel B, Constantin AL, Mariette X, Morel J, Gilson M, Cormier G, Salmon JH, Rist S, Lioté F, Marotte H, Bonnet C, Marcelli C, Sellam J, Meyer O, Solau-Gervais E, Guis S, Ziza JM, Zarnitsky C, Chary-Valckenaere I, Vittecoq O, Saraux A, Pers YM, Gayraud M, Bolla G, Claudepierre P, Ardizzone M, Dernis E, Breban MA, Fain O, Balblanc JC, Aberkane O, Vazel M, Back C, Candon S, Chatenoud L, Perrodeau E, Sibilia J, Ravaud P.

JAMA. 2016 Sep 20;316(11):1172-1180. doi: 10.1001/jama.2016.13512.

PMID:
27654603
27.

Precision medicine for autoimmune disease.

Chatenoud L.

Nat Biotechnol. 2016 Sep 8;34(9):930-2. doi: 10.1038/nbt.3670. No abstract available.

PMID:
27606458
28.

Filaggrin gene loss-of-function variants modify the effect of breast-feeding on eczema risk in early childhood.

Ziyab AH, Mukherjee N, Ewart S, Arshad SH, Karmaus W, Turati F, Bertuccio P, Galeone C, Pelucchi C, Naldi L, Bach JF, Vecchia CL, Chatenoud L.

Allergy. 2016 Sep;71(9):1371-3. doi: 10.1111/all.12940. No abstract available.

PMID:
27492891
29.

Triggering the TCR Developmental Checkpoint Activates a Therapeutically Targetable Tumor Suppressive Pathway in T-cell Leukemia.

Trinquand A, Dos Santos NR, Tran Quang C, Rocchetti F, Zaniboni B, Belhocine M, Da Costa de Jesus C, Lhermitte L, Tesio M, Dussiot M, Cosset FL, Verhoeyen E, Pflumio F, Ifrah N, Dombret H, Spicuglia S, Chatenoud L, Gross DA, Hermine O, Macintyre E, Ghysdael J, Asnafi V.

Cancer Discov. 2016 Sep;6(9):972-85. doi: 10.1158/2159-8290.CD-15-0675. Epub 2016 Jun 28.

30.

Regulatory mechanisms of immune tolerance in type 1 diabetes and their failures.

Kuhn C, Besançon A, Lemoine S, You S, Marquet C, Candon S, Chatenoud L.

J Autoimmun. 2016 Jul;71:69-77. doi: 10.1016/j.jaut.2016.05.002. Epub 2016 May 21. Review.

PMID:
27216249
31.

Early weaning is beneficial to prevent atopic dermatitis occurrence in young children.

Turati F, Bertuccio P, Galeone C, Pelucchi C, Naldi L, Bach JF, La Vecchia C, Chatenoud L; HYGIENE Study Group.

Allergy. 2016 Jun;71(6):878-88. doi: 10.1111/all.12864. Epub 2016 Mar 4.

PMID:
26893011
32.

Inducing and Administering Tregs to Treat Human Disease.

Perdigoto AL, Chatenoud L, Bluestone JA, Herold KC.

Front Immunol. 2016 Jan 22;6:654. doi: 10.3389/fimmu.2015.00654. eCollection 2015. Review.

33.

TGFβ-dependent expression of PD-1 and PD-L1 controls CD8(+) T cell anergy in transplant tolerance.

Baas M, Besançon A, Goncalves T, Valette F, Yagita H, Sawitzki B, Volk HD, Waeckel-Enée E, Rocha B, Chatenoud L, You S.

Elife. 2016 Jan 29;5:e08133. doi: 10.7554/eLife.08133.

34.

Correction: Antibiotics in Early Life Alter the Gut Microbiome and Increase Disease Incidence in a Spontaneous Mouse Model of Autoimmune Insulin-Dependent Diabetes.

Candon S, Perez-Arroyo A, Marquet C, Valette F, Foray AP, Pelletier B, Milani C, Ventura M, Bach JF, Chatenoud L.

PLoS One. 2016 Jan 22;11(1):e0147888. doi: 10.1371/journal.pone.0147888. eCollection 2016. No abstract available.

35.

World Diabetes Day: Perspectives on immunotherapy of Type 1 Diabetes.

Chatenoud L.

Eur J Immunol. 2015 Nov;45(11):2968-70. doi: 10.1002/eji.201570114. No abstract available.

36.

Autoimmune Diabetes: An Overview of Experimental Models and Novel Therapeutics.

You S, Chatenoud L.

Methods Mol Biol. 2016;1371:117-42. doi: 10.1007/978-1-4939-3139-2_8.

PMID:
26530798
37.

Long-term CD4 lymphopenia is associated with accelerated decline of kidney allograft function.

Luque Y, Jamme M, Rabant M, DeWolf S, Noël LH, Thervet E, Chatenoud L, Snanoudj R, Anglicheau D, Legendre C, Candon S, Zuber J.

Nephrol Dial Transplant. 2016 Mar;31(3):487-95. doi: 10.1093/ndt/gfv362. Epub 2015 Oct 22.

PMID:
26492923
38.

Control of Immune Response to Allogeneic Embryonic Stem Cells by CD3 Antibody-Mediated Operational Tolerance Induction.

Calderon D, Prot M, You S, Marquet C, Bellamy V, Bruneval P, Valette F, de Almeida P, Wu JC, Pucéat M, Menasché P, Chatenoud L.

Am J Transplant. 2016 Feb;16(2):454-67. doi: 10.1111/ajt.13477. Epub 2015 Oct 22.

39.

Concise Review: Pluripotent Stem Cell-Derived Cardiac Cells, A Promising Cell Source for Therapy of Heart Failure: Where Do We Stand?

Gouadon E, Moore-Morris T, Smit NW, Chatenoud L, Coronel R, Harding SE, Jourdon P, Lambert V, Rucker-Martin C, Pucéat M.

Stem Cells. 2016 Jan;34(1):34-43. doi: 10.1002/stem.2205. Epub 2015 Sep 16. Review.

40.

Laryngeal cancer mortality trends in European countries.

Chatenoud L, Garavello W, Pagan E, Bertuccio P, Gallus S, La Vecchia C, Negri E, Bosetti C.

Int J Cancer. 2016 Feb 15;138(4):833-42. doi: 10.1002/ijc.29833. Epub 2015 Sep 14.

41.

Biotherapies targeting T and B cells: from immune suppression to immune tolerance.

Chatenoud L.

Curr Opin Pharmacol. 2015 Aug;23:92-7. doi: 10.1016/j.coph.2015.05.013. Epub 2015 Jun 19. Review.

PMID:
26099946
42.

Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART.

Lapadula G, Chatenoud L, Gori A, Castelli F, Di Giambenedetto S, Fabbiani M, Maggiolo F, Focà E, Ladisa N, Sighinolfi L, Di Pietro M, Pan A, Torti C; Italian MASTER Cohort.

PLoS One. 2015 May 28;10(5):e0124741. doi: 10.1371/journal.pone.0124741. eCollection 2015.

43.

Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes.

Candon S, Perez-Arroyo A, Marquet C, Valette F, Foray AP, Pelletier B, Milani C, Ventura M, Bach JF, Chatenoud L.

PLoS One. 2015 May 13;10(5):e0125448. doi: 10.1371/journal.pone.0125448. eCollection 2015. Erratum in: PLoS One. 2016;11(1):e0147888. Milani, Cristian [corrected to Milani, Christian].

44.

Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients.

Lapadula G, Costarelli S, Chatenoud L, Castelli F, Astuti N, Di Giambenedetto S, Quiros-Roldan E, Sighinolfi L, Ladisa N, Di Pietro M, Zoncada A, Di Filippo E, Gori A, Nasta P, Torti C; Italian MASTER Cohort.

J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):312-8. doi: 10.1097/QAI.0000000000000585.

PMID:
25723139
45.

Restricted specificity of peripheral alloreactive memory B cells in HLA-sensitized patients awaiting a kidney transplant.

Snanoudj R, Claas FH, Heidt S, Legendre C, Chatenoud L, Candon S.

Kidney Int. 2015 Jun;87(6):1230-40. doi: 10.1038/ki.2014.390. Epub 2015 Jan 7.

46.

Long live the Italians!

Gallus S, Bosetti C, Chatenoud L, La Vecchia C.

Prev Med. 2015 Jan;70:76-7. doi: 10.1016/j.ypmed.2014.11.015. Epub 2014 Nov 28. No abstract available.

PMID:
25448842
47.

Combining autologous dendritic cell therapy with CD3 antibodies promotes regulatory T cells and permanent islet allograft acceptance.

Baas MC, Kuhn C, Valette F, Mangez C, Duarte MS, Hill M, Besançon A, Chatenoud L, Cuturi MC, You S.

J Immunol. 2014 Nov 1;193(9):4696-703. doi: 10.4049/jimmunol.1401423. Epub 2014 Sep 24.

48.

The impact of dietary therapy on clinical and biologic parameters of pediatric patients with eosinophilic esophagitis.

Colson D, Kalach N, Soulaines P, Vannerom Y, Campeotto F, Talbotec C, Chatenoud L, Hankard R, Dupont C.

J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):587-93. doi: 10.1016/j.jaip.2014.05.012.

PMID:
25213053
49.

Casein-specific IL-4- and IL-13-secreting T cells: a tool to implement diagnosis of cow's milk allergy.

Michaud B, Aroulandom J, Baiz N, Amat F, Gouvis-Echraghi R, Candon S, Foray AP, Couderc R, Bach JF, Chatenoud L, Just J.

Allergy. 2014 Nov;69(11):1473-80. doi: 10.1111/all.12484. Epub 2014 Aug 30.

PMID:
25041079
50.

Immunology. Teaching the immune system "self" respect and tolerance.

Chatenoud L.

Science. 2014 Jun 20;344(6190):1343-4. doi: 10.1126/science.1256864. No abstract available.

PMID:
24948722

Supplemental Content

Loading ...
Support Center